Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2024

01-08-2023 | Original Research

Evaluating the Impact of the Novel Geographic Preferences Section on Interview Rate and Residency Match Outcomes

Authors: William J. Benjamin, MPH, Nicholas R. Lenze, MD, MPH, Lauren A. Bohm, MD, Marc C. Thorne, MD, MPH, Robbi A. Kupfer, MD, Dan Sepdham, MD, Angela P. Mihalic, MD, Reeni Abraham, MD

Published in: Journal of General Internal Medicine | Issue 3/2024

Login to get access

Abstract  

Background

The American Association of Medical Colleges trialed residency application initiatives including geographic preferences and preference signals in 2022.

Objective

To assess the impact of geographic preferences on application outcomes during the 2022 residency match year.

Design

Cross-sectional.

Participants

Applicants to categorical and preliminary internal medicine during the 2022 application cycle who completed the Texas Seeking Transparency in Applications to Residency survey.

Main Measures

The primary outcome was interview rate (interview offers/total applications) and whether an application resulted in a match. The key dependent variables were geographic preferences and program-specific preference signals. We also assessed differences in utilization of geographic preferences between specialties.

Key Results

A total of 970 applicants into categorical (n = 884) and preliminary (n = 86) internal medicine were included in our study. A total of 704 (72.6%) applicants submitted at least one geographic preference and 424 (43.7%) submitted three preferences. On average, applicants who submitted a geographic preference had a higher interview rate than those who did not (46.0% vs. 41.8%). Applications submitted with both a preference signal and geographic preference were significantly more likely to receive an interview offer (OR: 3.2, p < 0.01) and match (OR: 6.4, p < 0.01) than applications with neither a preference signal nor a geographic preference. Geographic preferences were associated with an increase in the odds of an application receiving an interview offer, even in the setting of a preference signal (OR: 1.4, p < 0.01).

Conclusions

Both preference signals and geographic preferences have significant associations with odds of an application receiving an interview and matching for both categorical and preliminary internal medicine applicants. This study can be used to inform applicants, advisors, and programs how novel application strategies can affect important application outcomes for US medical school graduates. As more specialties pilot alternative processes, it will be important to study all application outcomes among varying applicant populations.
Appendix
Available only for authorised users
Literature
14.
go back to reference Supplemental ERAS Application Guide 2021. AAMC; 2021. Supplemental ERAS Application Guide 2021. AAMC; 2021.
Metadata
Title
Evaluating the Impact of the Novel Geographic Preferences Section on Interview Rate and Residency Match Outcomes
Authors
William J. Benjamin, MPH
Nicholas R. Lenze, MD, MPH
Lauren A. Bohm, MD
Marc C. Thorne, MD, MPH
Robbi A. Kupfer, MD
Dan Sepdham, MD
Angela P. Mihalic, MD
Reeni Abraham, MD
Publication date
01-08-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 3/2024
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08342-w

Other articles of this Issue 3/2024

Journal of General Internal Medicine 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine